Terms: = Sarcomas AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Prognosis
7 results:
1. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
2. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and tsc2 ubiquitination.
Tsang SV; Rainusso N; Liu M; Nomura M; Patel TD; Nakahata K; Kim HR; Huang S; Rajapakshe K; Coarfa C; Man TK; Rao PH; Yustein JT
Oncogene; 2022 Dec; 41(50):5373-5384. PubMed ID: 36348010
[TBL] [Abstract] [Full Text] [Related]
4. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract] [Full Text] [Related]
5. Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.
Smolle MA; Schaffler A; Leithner A; Van Praag VM; Bergovec M; Szkandera J; Liegl-Atzwanger B; Niethard M; Tunn PU; Van De Sande M; Andreou D
J Surg Oncol; 2020 Mar; 121(4):605-611. PubMed ID: 32003475
[TBL] [Abstract] [Full Text] [Related]
6. Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas.
Liang X; Li Q; Xu B; Hu S; Wang Q; Li Y; Zong Y; Zhang S; Li C
Int J Clin Oncol; 2019 Sep; 24(9):1061-1068. PubMed ID: 31065835
[TBL] [Abstract] [Full Text] [Related]
7. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
